420 related articles for article (PubMed ID: 8276045)
21. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
Nilsell K; Angelin B; Leijd B; Einarsson K
Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
[TBL] [Abstract][Full Text] [Related]
22. Ursodeoxycholic acid for chronic liver diseases.
Podda M; Ghezzi C; Battezzati PM; Bertolini E; Crosignani A; Petroni ML; Zuin M
J Clin Gastroenterol; 1988; 10 Suppl 2():S25-31. PubMed ID: 3062082
[TBL] [Abstract][Full Text] [Related]
23. Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health.
Dilger K; Hohenester S; Winkler-Budenhofer U; Bastiaansen BA; Schaap FG; Rust C; Beuers U
J Hepatol; 2012 Jul; 57(1):133-40. PubMed ID: 22414767
[TBL] [Abstract][Full Text] [Related]
24. Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response.
van de Meeberg PC; Wolfhagen FH; Van Berge-Henegouwen GP; Salemans JM; Tangerman A; van Buuren HR; van Hattum J; van Erpecum KJ
J Hepatol; 1996 Dec; 25(6):887-94. PubMed ID: 9007717
[TBL] [Abstract][Full Text] [Related]
25. Improved liver tests and greater biliary enrichment with high dose ursodeoxycholic acid in early stage primary biliary cirrhosis.
Roda E; Azzaroli F; Nigro G; Piazza F; Jaboli F; Ferrara F; Liva S; Giovanelli S; Miracolo A; Colecchia A; Festi D; Mazzeo C; Bacchi L; Roda A; Mazzella G
Dig Liver Dis; 2002 Jul; 34(7):523-7. PubMed ID: 12236487
[TBL] [Abstract][Full Text] [Related]
26. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
[TBL] [Abstract][Full Text] [Related]
27. Influence of portacaval anastomosis on serum and biliary unsulfated bile acid composition in patients with liver cirrhosis.
Angelico M; Attili AF; Bracci F; Di Biase A; Paciscopi L; Puoti C; Capocaccia L
Dig Dis Sci; 1979 Nov; 24(11):829-34. PubMed ID: 520101
[TBL] [Abstract][Full Text] [Related]
28. Unsaturated monohydroxy bile acids in cholestatic liver disease.
Murphy GM; Jansen FH; Billing BH
Biochem J; 1972 Sep; 129(2):491-4. PubMed ID: 4643332
[No Abstract] [Full Text] [Related]
29. Long-Term Ursodeoxycholic Acid Therapy Does Not Alter Lithocholic Acid Levels in Patients with Cystic Fibrosis with Associated Liver Disease.
Colombo C; Crosignani A; Alicandro G; Zhang W; Biffi A; Motta V; Corti F; Setchell KDR
J Pediatr; 2016 Oct; 177():59-65.e1. PubMed ID: 27297203
[TBL] [Abstract][Full Text] [Related]
30. Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration.
Crosignani A; Podda M; Battezzati PM; Bertolini E; Zuin M; Watson D; Setchell KD
Hepatology; 1991 Dec; 14(6):1000-7. PubMed ID: 1959845
[TBL] [Abstract][Full Text] [Related]
31. Ursodeoxycholic acid therapy in primary biliary cirrhosis.
Leuschner U
Scand J Gastroenterol Suppl; 1994; 204():40-6. PubMed ID: 7824877
[TBL] [Abstract][Full Text] [Related]
32. Effects of bile acid depletion and of ursodeoxycholic and chenodeoxycholic acids on biliary protein secretion in the hamster.
Malavolti M; Fromm H; Ceryak S; Shehan KL
Life Sci; 1990; 46(23):1727-37. PubMed ID: 2355803
[TBL] [Abstract][Full Text] [Related]
33. Effect of dietary fiber on serum bile acids in patients with chronic cholestatic liver disease under ursodeoxycholic acid therapy.
Sauter G; Beuers U; Paumgartner G
Digestion; 1995; 56(6):523-7. PubMed ID: 8536824
[TBL] [Abstract][Full Text] [Related]
34. Bile acid metabolism in cirrhosis. IV. Characterization of the abnormality in deoxycholic acid metabolism.
Yoshida T; McCormick WC; Swell L; Vlahcevic ZR
Gastroenterology; 1975 Feb; 68(2):335-41. PubMed ID: 1116679
[TBL] [Abstract][Full Text] [Related]
35. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?
Poupon R; Chrétien Y; Poupon RE; Ballet F; Calmus Y; Darnis F
Lancet; 1987 Apr; 1(8537):834-6. PubMed ID: 2882236
[TBL] [Abstract][Full Text] [Related]
36. Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis.
Poupon RE; Ouguerram K; Chrétien Y; Verneau C; Eschwège E; Magot T; Poupon R
Hepatology; 1993 Apr; 17(4):577-82. PubMed ID: 8477962
[TBL] [Abstract][Full Text] [Related]
37. Ursodeoxycholic acid in primary biliary cirrhosis: no evidence for toxicity in the stages I to III.
Lotterer E; Stiehl A; Raedsch R; Foelsch UR; Bircher J
J Hepatol; 1990 May; 10(3):284-90. PubMed ID: 2365981
[TBL] [Abstract][Full Text] [Related]
38. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
[TBL] [Abstract][Full Text] [Related]
39. [Effects of ursodeoxycholic acid on the biliary lipids secretion (author's transl)].
Yanaura S; Izuka A; Ishikawa S
Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):261-7. PubMed ID: 7327454
[TBL] [Abstract][Full Text] [Related]
40. Faecal bile acid loss and bile acid pool size during short-term treatment with ursodeoxycholic and chenodeoxycholic acid in patients with radiolucent gallstones.
Salvioli G; Salati R
Gut; 1979 Aug; 20(8):698-704. PubMed ID: 488763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
